Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes

NCT04861207 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia Myelodysplastic Syndromes

Interventions

DRUG: Cladribine

Sponsor

Maria Sklodowska-Curie National Research Institute of Oncology

Collaborators

[object Object]